Comment
. 2006 Aug;244(2):332-3; author reply 333.
doi: 10.1097/01.sla.0000229980.81505.44.
On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer
- PMID: 16858208
- PMCID: PMC1602155
- DOI: 10.1097/01.sla.0000229980.81505.44
Item in Clipboard
Comment
On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer
Ann Surg.
2006 Aug.
No abstract available
Comment on
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4. doi: 10.1097/00000658-199912000-00006. Ann Surg. 1999. PMID: 10615932 Free PMC article. Clinical Trial.
Similar articles
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.Ann Surg. 2000 Nov;232(5):727. doi: 10.1097/00000658-200011000-00028. Ann Surg. 2000. PMID: 11066157 Free PMC article. No abstract available.
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.Ann Surg. 2000 Nov;232(5):726-7. doi: 10.1097/00000658-200011000-00027. Ann Surg. 2000. PMID: 11066156 Free PMC article. No abstract available.
-
Adjuvant therapy for pancreatic and periampullary cancer.Trop Gastroenterol. 2000 Jul-Sep;21(3):129-30. Trop Gastroenterol. 2000. PMID: 11084835 No abstract available.
-
Role of adjuvant therapy in the management of pancreatic cancer.Adv Surg. 2005;39:223-44. doi: 10.1016/j.yasu.2005.05.003. Adv Surg. 2005. PMID: 16250554 Review. No abstract available.
-
Chemoradiation for localized pancreatic cancer: another perspective.Ann Surg Oncol. 1999 Jan-Feb;6(1):4-7. doi: 10.1007/s10434-999-0004-9. Ann Surg Oncol. 1999. PMID: 10030405 Review. No abstract available.
Cited by
-
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer.J Gastrointest Surg. 2012 Apr;16(4):753-61. doi: 10.1007/s11605-011-1811-4. Epub 2012 Feb 7. J Gastrointest Surg. 2012. PMID: 22311282 Free PMC article.
-
Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".Drugs. 2007;67(17):2487-90; discussion 2491-3. doi: 10.2165/00003495-200767170-00002. Drugs. 2007. PMID: 18034586 Review. No abstract available.
-
Pancreas cancer survival in the gemcitabine era.Clin Med Oncol. 2008;2:405-13. doi: 10.4137/cmo.s334. Epub 2008 Apr 29. Clin Med Oncol. 2008. PMID: 21892307 Free PMC article.
-
Current and emerging therapies for the treatment of pancreatic cancer.Onco Targets Ther. 2010 Sep 7;3:111-27. doi: 10.2147/ott.s7203. Onco Targets Ther. 2010. PMID: 20856847 Free PMC article.
-
Adjuvant therapy in pancreatic cancer: a critical appraisal.Drugs. 2007;67(16):2293-310. doi: 10.2165/00003495-200767160-00001. Drugs. 2007. PMID: 17983252 Review.
References
-
- Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899–903. - PubMed
-
- Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006–2010. - PubMed
-
- Green S, Benedetti J, Crowley J, eds. Clinical Trials in Oncology (Interdisciplinary Statistics). Boca Raton, FL: Chapman & Hall/CRC Press, 1997.
-
- Radiation Therapy Oncology Group. RTOG 97-04. (accessible at http://rtog.org/members/protocols/97-04/97-04.pdf).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
